Diabetes
-
Glenmark Pharmaceuticals introduces innovative triple-drug combination for type 2 diabetes
INDIA — Glenmark Pharmaceuticals has launched a triple-drug fixed-dose combination (FDC) in India, known as Zita DM. This innovative FDC combines Teneligliptin (20mg), Dapagliflozin (10mg),…
-
AI-powered voice analysis tool detects diabetes, while MIT develops innovative diabetes treatment
USA — Researchers at Klick Labs have designed an AI-driven voice analysis tool capable of detecting Type 2 diabetes with a high degree of accuracy.…
-
Novo Nordisk halts clinical trial of diabetes drug due to positive kidney benefits
DENMARK — Novo Nordisk has announced the early termination of a significant clinical trial assessing the efficacy of its diabetes drug, Ozempic, after preliminary data…
-
Eli Lilly makes strategic leadership changes in anticipation of FDA’s decision on Mounjaro
USA — In the dynamic landscape of the pharmaceutical industry, Eli Lilly is poised for a transformative period. While awaiting a crucial FDA decision in…
-
Abbott augments its diabetes management portfolio with Bigfoot Biomedical acquisition
USA —Abbott Laboratories, Inc. has concluded its acquisition of Bigfoot Biomedical—an innovative force in intelligent insulin management systems. While financial specifics remain undisclosed, the implications…
-
Aspen Pharmacare and Novo Nordisk pioneer local insulin production in Africa to tackle diabetes crisis
SOUTH AFRICA — Africa’s leading pharmaceutical company, Aspen Pharmacare, has entered into a groundbreaking agreement with Danish healthcare firm Novo Nordisk to establish South Africa’s…
-
NICE recommends Eli Lilly’s Mounjaro for treating type 2 diabetes in a turnaround decision
UNITED KINGDOM — In a surprising turn of events, the National Institute for Health and Care Excellence (NICE) has issued final draft guidance endorsing Eli…
-
Novo’s Wegovy proves beneficial for individuals with obesity and heart failure
DENMARK — Novo Nordisk, the Danish pharmaceutical giant, has once again seized the spotlight with groundbreaking revelations about its weight loss drug, Wegovy. Following its…
-
Amazon’s pioneering move aims at reinventing access to insulin and diabetes care
USA — In a pioneering stride aimed at transforming access to vital diabetes care, Amazon has introduced a remarkable expansion of its online pharmacy offerings,…
-
RAK Hospital reiterates its support for diabetes management with a 3-month health challenge
UAE – RAK Hospital is rolling out a 3-month-long health challenge, titled RAK Diabetes Challenge 2023, to increase the engagement of residents in the management…